Skip to content
Open access

Recruitment of Cas3 enables DNA cleavage by the type I-A CRISPR-Cas system of Saccharolobus islandicus.

Aug 2026 · Cell Reports · Vol 45 8, pp. 117820 · 1 citation · 73 references
Medicine

TL;DR

This study isolates the I-A Cascade from Saccharolobus islandicus, revealing a minimal form of Cascade lacking both Cas3 and the CRISPR-RNA maturase Cas6, and shows that ATP not only enables the processive target degradation by Cas3 but also suppresses the trans-cleavage of the same enzyme.

Abstract

Type I CRISPR-Cas systems constitute the most prevalent prokaryotic adaptive immune pathways and are classified into seven subtypes (I-A to I-G). These antiviral systems typically exploit a Cascade complex for RNA-guided DNA recognition and a Cas3 helicase-nuclease effector for DNA degradation, yet their diverse activation mechanisms remain not fully understood. In this study, we isolate the I-A Cascade from Saccharolobus islandicus, revealing a minimal form of Cascade lacking both Cas3 and the CRISPR-RNA maturase Cas6. Cas3 is recruited to the R-loop structure formed after Cascade binding to target DNA, which activates the effector for both cis- and trans-DNA cleavage. Strikingly, ATP not only enables the processive target degradation by Cas3 but also suppresses the trans-cleavage of the same enzyme. Together, the Sa. islandicus I-A system operates via target-dependent Cas3 recruitment-a mechanism distinct from other characterized I-A systems, thus underscoring the mechanistic diversity within type I CRISPR-Cas immunity.

Read PDF

Similar papers

Open access Sep 2026

Type IV-C CRISPR-Cas effector complexes recognize double-stranded DNA and switch on collateral cleavage of ssDNA and RNA.

Type IV-C CRISPR-Cas systems remain enigmatic compared to other class 1 systems. Here, we expand the type IV-C catalog, identifying two phylogenetically distinct clades primarily found in archaea (IV-C1) or bacteria (IV-C2), distinguishable by the Cas10IVc subunit architecture. We functionally and structurally characte...

Conor C. Pittman, Cheng-Tao Xu, Ryan J. Catchpole et al. · 0 citations
Open access Aug 2026

A tRNA-derived second messenger mediates antiviral defense

CRISPR-Cas systems are RNA-guided nucleases that enable prokaryotic immunity; however, some loci encode additional associated genes that cooperate with CRISPR effectors to perform diverse biological functions. Here, we uncover a CRISPR-associated kinase (CASK) system that links the recognition of target RNA to protein...

Yang Liu, Yan Qin, Imane Bouzit et al. · 0 citations
Review Open access Sep 2026

When Homing Endonuclease Meets Transposon: The OMEGA System

Simple Summary The CRISPR-Cas9 and CRISPR-Cas12 systems recognize target DNA through base pairing with their guide RNAs, revolutionarily simplifying the design of DNA endonucleases with novel target-sequence specificity for genome editing and gene therapy, compared with endonucleases that rely on protein-based target r...

Kenji K. Kojima · 0 citations
Open access Aug 2026

Compact type II-D Cas9 nucleases for efficient and specific genome editing

Five previously uncharacterized MG102-like Cas9d orthologs are identified that share the hallmark genomic, sequence, and structural features of type II-D Cas9 and establish compact MG102-like Cas9d orthologs as robust and specific genome editors and provide promising, single-AAV– compatible scaffolds for in vivo therap...

Qiaochu Wang, Ahmed Saleh, G. S. Rao et al. · 0 citations
Open access Sep 2026

Interfering with DNA repair pathways to enhance CRISPR-Cas9-mediated homology-directed repair in a chelicerate genetic model

Summary The two-spotted spider mite, Tetranychus urticae, is a major pest and an emerging genetic model. Recent CRISPR-Cas9 advances, especially the SYNCAS method for maternal delivery of Cas9 ribonucleoproteins, have enabled precise genome editing in this and other difficult-to-transform arthropods. Yet SYNCAS-mediate...

S. De Rouck, W. Dermauw, T. van Leeuwen · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.